Triple Hair
Triple Hair
  • Publications
  • Contact
  • FR
  • Products
    • PRESCRIPTION
      • Therapy-07
    • DRUG-FREE
      • Therapy-16
    • RIZN
    • Plenty Natural
  • Company
  • Science
  • Investors
  • Clinical trials
  • Products
    • PRESCRIPTION l Therapy-7
    • DRUG-FREE l Therapy-16
    • Hair Loss Rx Consult
    • RIZN
    • Plenty Natural
  • Company
  • Science
  • Investors
  • Clinical trials

Category: Corporate

Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India

Posted on October 23, 2024 by Pascale Bouchard

[…]

Read More…

Posted in CorporateLeave a comment

Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe

Posted on June 19, 2024 (June 19, 2024) by Pascale Bouchard

[…]

Read More…

Posted in CorporateLeave a comment

Triple Hair Group Closes $4 Million Financing

Posted on June 3, 2024 by Pascale Bouchard

[…]

Read More…

Posted in Corporate, In the mediasLeave a comment

Triple Hair Wins “Jury’s Choice Award” at Octane Aesthetic Tech Forum

Posted on February 12, 2024 (February 12, 2024) by Pascale Bouchard
CEO win a trophy at Octane OC

[…]

Read More…

Posted in Corporate, In the mediasLeave a comment

Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s Pharmaceutical

Posted on October 17, 2023 (February 15, 2024) by Pascale Bouchard

[…]

Read More…

Posted in Corporate, In the mediasLeave a comment

OpportunitiesNB Article on an interview with our CEO Jean-Phillipe Gravel

Posted on July 27, 2023 by Pascale Bouchard

[…]

Read More…

Posted in Corporate, In the mediasLeave a comment

Triple Hair Group receives Health Canada approval to start Phase III clinical trials on its Therapy-07 prescription drug in Canada

Posted on June 28, 2023 by Pascale Bouchard

[…]

Read More…

Posted in Corporate, ScienceLeave a comment

Triple Hair Group consolidates its position as industry leader and innovator for its Therapy-07 prescription drug in the U.S.

Posted on June 19, 2023 by Pascale Bouchard

[…]

Read More…

Posted in Corporate, ScienceLeave a comment

Triple Hair Group Reports Positive Results from Safety Studies on its Therapy-07 Prescription Drug

Posted on June 14, 2023 by Pascale Bouchard
Laboratoire

[…]

Read More…

Posted in Corporate, ScienceLeave a comment

New Possibilities in Hair Loss Prescription Therapies

Posted on August 11, 2022 (August 11, 2022) by Julie-Anne Rioux

[…]

Read More…

Posted in Corporate, In the medias, ScienceLeave a comment

Posts navigation

  • 1
  • 2
  • 3
  • »

Search

Recent Posts

  • TH07 Clinical Study Featured in Peer-Reviewed Scientific Journal
  • Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India
  • Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe
  • Triple Hair’s Feature in Le Journal de Montréal
  • Triple Hair Group Closes $4 Million Financing

Recent Comments

    Triple Hair is a clinical-stage Canadian
    biotechnology company specialized in the
    development of innovative treatments for alopecia.

    Revolutionary
    hair growth
    therapies

    • Company
    • Products
    • Therapy-07
    • Science
    • Contact
    • Therapy-16
    • Investors
    • Terms and Conditions
    • Privacy Policy

    Copyright © 2020 | Triple Hair

    Clinical Trials
    Looking to invest?